• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】62298

【品名】(3R,4S,5R,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-12,13-dihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexame

【CA登记号】

【 分 子 式 】C41H73NO13

【 分 子 量 】788.02956

【元素组成】C 62.49% H 9.34% N 1.78% O 26.39%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(XIX)

Removal of the oxime functionality of (XVIII) by means of sodium hydrosulfite and formic acid gives ketone (XIX). The C-3 sugar moiety is then cleaved under smooth acidic hydrolysis conditions yielding the des-cladinose analogue (XX). After protection of the 2'-hydroxyl group of the desosamine moiety of (XX) as the benzoate ester (XXI), its 3-hydroxyl is oxidized with either NCS/Me2S or with DMSO/EDC, producing the ketolide derivative (XXII). The C-11 secondary hydroxyl of (XXII) is then converted to mesylate (XXIII) by treatment with methanesulfonyl chloride in pyridine.

1 Macielag, M.; Abbanat, D.; Ashley, G.; Foleno, B.; Fu, H.; Li, Y.; Wira, E.; Bush, K.; Structure-activity studies of 15-methyl ketolides: Optimization of the heterocyclic substituent. 42nd Intersci Conf Antimicrob Agents Chemother (Sept 27 2002, San Diego) 2002, Abst F-1662.
2 Hlasta, D.; Khosla, C.; Chu, D.T.W.; Ashley, G.; Henninger, T.C.; Grant, E.B. (Ortho-McNeil Pharmaceutical, Inc.); Ketolide antibacterials. WO 0232918 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XVIII) 62297 (3R,4S,5R,6R,7S,9R,11S,12R,13S,14R)-7-(allyloxy)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-12,13-dihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexame C41H74N2O13 详情 详情
(XIX) 62298 (3R,4S,5R,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-12,13-dihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexame C41H73NO13 详情 详情
(XX) 62299 (3R,4S,5S,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-14-propyl-2,10-oxacyclotetradecanedione C33H59NO10 详情 详情
(XXI) 62300 (2S,3R,4S,6R)-2-{[(3R,4S,5S,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-4,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-14-propyloxacyclotetradecanyl]oxy}-4-(dimethylamino)-6-methyltetrahydro-2H-pyran-3-yl benzoate C40H63NO11 详情 详情
(XXII) 62301 (2S,3R,4S,6R)-2-{[(3R,5R,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-12,13-dihydroxy-3,5,7,9,11,13-hexamethyl-2,4,10-trioxo-14-propyloxacyclotetradecanyl]oxy}-4-(dimethylamino)-6-methyltetrahydro-2H-pyran-3-yl benzoate C40H61NO11 详情 详情
(XXIII) 62303 (2S,3R,4S,6R)-2-({(3R,5R,6R,7S,9R,11R,12R,13R,14R)-7-(allyloxy)-13-hydroxy-3,5,7,9,11,13-hexamethyl-12-[(methylsulfonyl)oxy]-2,4,10-trioxo-14-propyloxacyclotetradecanyl}oxy)-4-(dimethylamino)-6-methyltetrahydro-2H-pyran-3-yl benzoate C41H63NO13S 详情 详情
Extended Information